MétaCan
Menu
← Back to cohort

Phase III trial of antioxidant vitamins to prevent acute side effects of radiation therapy in head and neck cancer (HNC) patients

2005· article· en· W2203437270 on OpenAlexaff
Isabelle Bairati, F. Meyer, A. Fortin, Bernard Têtu, François Harel, Belkacem Abdous, Malorie Gélinas, Abdenour Nabid, François Brochet

Bibliographic record

VenueJournal of Clinical Oncology · 2005
Typearticle
Languageen
FieldMedicine
TopicHead and Neck Cancer Studies
Canadian institutionsCentre Hospitalier Universitaire de Sherbrooke
Fundersnot available
KeywordsMedicineHazard ratioPlaceboInternal medicineRandomized controlled trialRadiation therapyHead and neck cancerConfidence intervalOdds ratioPopulationVitamin EInterim analysisSurgeryAntioxidantPathology

Abstract

fetched live from OpenAlex

3017 Background: Many cancer patients take antioxidant vitamins in the hope of improving the outcome of therapies and of reducing treatments side effects. We conducted a randomized trial to determine whether a supplementation with antioxidant vitamins could reduce the occurrence and severity of acute side effects of radiation therapy (ASERT) and improve quality of life without compromising treatment efficacy (second objective of the trial). Methods: This randomized, double-blind, placebo-controlled trial was conducted among 540 stage I or II HNC patients treated by radiation therapy. The supplementation with alpha tocopherol (400 IU/day) and beta carotene (30 mg/day) or placebos was given during radiation therapy and for 3 years thereafter. From October, 1994 to June, 2000, 273 and 267 patients were randomized in the supplement and the placebo arms, respectively. This study population provided 91% power to detect a 50% reduction in the frequency of grade 3 and 4 ASERT in the supplement arm with two-sided α=0.05. In 1996, beta carotene was discontinued after recommendation of the trial’s ethical and safety monitoring committee. Ordinal logistic regression was used to estimate the cumulative odds ratios (OR) associated with ASERT one grade higher, with their 95% confidence intervals (CI). Cox proportional hazard model was used to estimate the hazard ratio of local recurrence. No interim analysis was conducted. Results: Patients in the supplement arm had less severe ASERT during radiation therapy (OR=0.72, 95% CI: 0.52–1.02). The reduction was statistically significant when the supplementation combined alpha tocopherol and beta carotene (OR=0.38, 95% CI: 0.20–0.74). Overall, quality of life was not improved by the supplementation. The rate of local recurrence of the HNC tended to be higher in the supplement arm: HR=1.37, 95% CI: 0.93- 2.02. Conclusions: Supplementation with high doses of alpha tocopherol and beta carotene during radiation therapy could reduce the severity of ASERT. However, high doses of antioxidants as adjuvant therapy might compromise radiation treatment efficacy. No significant financial relationships to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.019

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.001
Bibliometrics0.0000.000
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.062
GPT teacher head0.486
Teacher spread0.424 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2005
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicHead and Neck Cancer Studies→French-language works237,207→